15. Combined wealth of top 5 pharmaceutical companies outweighs GNP of sub-Saharan Africa.: Corporate Watch shows the public just how much wealth big pharmaceutical companies have, even on a global scale. Their report references The Guardian, which found that "the combined worth of the world’s top five drug companies is twice the combined GNP of all sub-Saharan Africa and their influence on the rules of world trade is many times stronger because they can bring their wealth to bear directly on the levers of western power."

16. Dr. Robert Jarvik isn't a licensed doctor: Many Americans watched as Dr. Robert Jarvik, inventor of the artificial heart, gently coaxed them to take the Pfizer-marketed drug Lipitor in order to lower their cholesterol. The ads were eventually pulled, however, when "it turn[ed] out Jarvik isn’t a licensed heart doctor." U.S. Representative John Dingell remarked, "It seems that Pfizer’s No. 1 priority is to sell lots of Lipitor, by whatever means necessary, including misleading the American people."

17. Ernesto Bertarelli makes Forbes' billionaires list: Just as Americans are questioning the record profits and salaries of booming oil companies when they're forced to accept rising prices at the pump, people may wonder about Ernesto Bertarelli's billionaire status. Bertarelli is the CEO of the pharmaceutical company Serono, and Forbes reports that his net worth in 2002 reached $8.4 billion. That was enough to place him as the 31st richest person in the world.

18. Pfizer is fifth-best wealth creator: Corporate Watch reports that Fortune named pharmaceutical giant Pfizer as the "fifth-best wealth-creator" in America, and Corporate Watch considers it the "largest and richest pharmaceutical enterprise in the world."

19. Americans pay more for prescription meds than anyone else in the world: The Media Matters website analyzes a 60 Minutes interview between correspondent Bob Simon and then Surgeon General Richard H. Carmona. During the segment, Carmona maintains that Americans pay more for brand name prescriptions than anyone else in the world because of the hefty price associated with "the research and development of drugs." See point number 3 on this list, which points out that drug companies pay more on advertising and marketing than they do on research and development.

20. Pharmaceutical advertisements actually work: The public wag their fingers at pharmaceutical companies' advertising budgets only if they admit that sometimes, those commercials actually work. The Miami Herald points out that while "more than four in ten [Americans] have an unfavorable view" of pharmaceutical companies, "prescription-drug advertising has driven a third of Americans to talk to their doctors about specific drugs, and many of these people got a prescription from their doctor as a result."

21. Americans spent $200 billion on prescription drugs in 2002: Marcia Angell reveals in her book The Truth About the Drug Companies that Americans spent $200 billion on prescription drugs in 2002. That's the amount experts estimated it will cost to rebuild New Orleans after Hurricane Katrina, and the amount China is pouring into an energy renewal program.

22. Academics help pharmaceutical companies conduct research: A new trend in the R&D sector of the pharmaceutical industry features research-based partnerships between academic centers and drug companies. Marcia Angell explains the collaboration by writing that these companies "now ring the major academic research institutions and often carry out the initial phases of drug development, hoping for lucrative deals with big drug companies that can market the new drugs. Usually both academic researchers and their institutions own equity in the biotechnology companies they are involved with," and everyone can "cash in on the public investment in research." As academic centers play a more significant role in the success of the drug companies, they are more likely to take on the "entrepreneur" spirit and make profits from patents, royalties and stocks, which can mark up the prices for everyday consumers.

23. "New" Drugs aren't really new: When a new drug hits the market, is it really new? Euractiv.com reports on a recent study which found "that two-thirds of the prescription drugs approved by the Food and Drug Administration between 1989 and 2000 were identical to existing drugs or modified versions of them. Only about one-third of the drugs approved by the FDA during the time period were based on new "molecular entities" that treat diseases in novel ways." Many of these newer drugs cost more because the drug companies have to extend their patents, which can "enable a brand company to delay generic competitors and maintain a high price for an aging product."

24. Some drug companies are taking advantage of underdeveloped countries to perform clinical trials: Wired.com reports that India is becoming a more attractive place for drug companies to run clinical trials and test out new drugs. The article explains, "more and more drug companies are conducting clinical trials in developing countries where government oversight is more lax and research can be done for a fraction of the cost." Controversy is starting to build over the trend, however, as one expert explains. Sean Philpott, managing editor of The American Journal of Bioethics, reveals to Wired.com that such practices may be unfair, as "individuals who participate in Indian clinical trials usually won't be educated. Offering $100 [as payment for their participation] may be undue enticement; they may not even realize that they are being coerced."

25. Pharmaceutical Companies donated millions to Hurricane Katrina relief programs: Americans are used to bashing pharmaceutical companies, just as they criticize health insurance companies, rising gas prices and monopolies. It may come as a shock, then, to discover the philanthropic efforts undertaken by big drug companies. Medical News Today writes that companies like Abbott, Eli Lilly, Merck, Pfizer and others have donated millions of dollars in cash and supplies to the Hurricane Katrina relief efforts.

Limited time offer!

Now through May10th



Get an 8 ounce Silver Solution® for

ONLY $24.95

(20 CV)



Or!



Buy 4 bottles at $24.95 each

and get one FREE!

($99.80/80 CV)





Plus receive a drawing entry for every bottle you purchase at this price.



Prizes:

1) Your choice of one following 3 items*

Senior Assortment Pack

Detox Pack

Case of 8 oz silver

2) 5 individual products of your choice FREE

3) 3 individual products of your choice FREE







Protect You and Your Family

Protect yourself every day by maintaining a strong immune system with The New Silver Solution®

“Your First Line of Defense”



Ø Doctor recommended

Ø Patented (Click HERE for Patent information.)

Ø Proven immune system support in clinical trials.

Ø Currently in use, world wide, by over 150,000+ satisfied customers.

Ø Safe and Non-Toxic.

Ø Broad spectrum anti-bacterial, anti-viral and anti-fungal.

New Product Announcement Tonight!



Hello Everyone!



We are very excited to announce the addition of an incredible new product to the Nutronix product line! This product will change your business! Be on the call tonight to find out what it is!



When: Tonight



Time: 8:00 PM EST



Call: 512-225-3039



Code: 42365#



Click HERE to listen online.

There is a new Version of the AutomaticBuilder site for The Berry Tree members now and not only Nutronix members.

Also this applies here
I got this reply from support about the New Senior Certificate (SAM = Senior Advantage Member)
Everyone can qualify for one, if you have an old Senior Certificate or you can make an order of at least 500cv
or buy the Senior Director Package through AutomaticBuilder

Thank you for your reply. The grace period for becoming a Senior Advantage Member (SAM) by purchasing a 500 CV order ends May 31st.

It gives you more money for life and not just 1 month like in the past.

Hello

The Conference Call Schedule for this week
is changed as follows:

THURSDAY NEW MEMBER TRAINING CALL will begin
at 9 P.M. EST instead of 9:30 as in the past.

THE SATURDAY ADVANCED TRAINING CALL has been
cancelled for this week because of the Memorial
Day Holiday in the United States. We will
return Saturday, May 31 at 11 A.M. EST.

JUST A REMINDER: For Current Members of The
Berry Tree who are NOT in their first 28 days
AND for Nutronix members who are not currently
enrolled in The Berry Tree, the month of May
is your last chance to qualify as a "SAM" in
The Berry Tree.

This would be an ideal time to review the
program at bnaadvantage.com and
plan your strategies for the implementation of
the new Berry Tree Comp Plan on June 1.

For more details about the new compensation
plan, visit btcompplan.com

Time is running short for members who want to
assure their positions as SAM's on June 1. So
why not take advantage of the time you would
ordinarily spend on the Saturday call and
TAKE ACTION.

You definitely will not want to miss out on all
of the many advantages, bonuses, drawings that
are available to you in the May promotions. To
get more information, visit:
berrybonus.com

You cannot afford to wait. $19,000 is up for
grabs for those who qualify and participate in
these fabulous May promotions.

Tuesday Night Product Calls

The Tuesday night product conference calls will be discontinued for the rest of the summer. Allan Hordal and I will resume the shceduled calls on Tuesday, September 2nd.

We wish you a healthy and successful summer!

Bob Bremner and Allan Hordal

PS. Remember: No softdrinks, and be sure to drink your O2 pH!

The New Silver Solution Look


We are pleased to announce that we have redesigned The New Silver Solution packaging. It is the same incredible product with a new look. Many of you will notice in the next few days that the 4-ounce Silver Solution has arrived in a blue bottle with a blue label. We started shipping these new bottles this week. In the next few weeks the packaging of the 8-ounce and 16-ounce bottles will change as well.



Here’s to your health!

The Nutronix Team

Personal Input
Great enhancement as this will make it easier for us to qualify for higher pay level in the payplan.


Volume Charts and Qualification Enhancements

Tomorrow, when commissions are run, you will see a change to the commission qualification charts. The 2 and 3 leg qualification charts both now contain the qualifications for Ruby, Emerald and Diamond. You will also find the 3 leg qualification chart listed first. These changes have streamlined the “Show Volume” charts to make it even easier for you to see your qualification level!

We have also enhanced the qualifications for reaching the Regional through Diamond levels with 3+ Personally Sponsored legs. We have increased the maximum volume that can be counted per leg from approximately 33% to 40% of the total required volume for each qualification level. This means more volume is counted from each leg towards your qualification! Also, we now allow each leg to be counted up to this new maximum. We are very excited about these enhancements and the positive effect it will have on your businesses.

To find more information about the Nutronix qualification, go to Nutronix.com and click "Opportunity."

Here’s to a healthy and financially secure future!

The Nutronix Team

There is a New Nutronix Catalog listing all the New products that were announced at the convention.
If you want to take a look it, please go to :

Nutronix - 2008

It really looks amazing, they have lots of products to choose from and one can even try them for free the first month with AutomaticBuilder.